optimizing duration and personalization of treatment in nsclc
Published 1 month ago • 20 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:06
optimizing precision medicine in nsclc
-
1:24
optimizing neoadjuvant therapy in nsclc with biomarker research
-
1:41
recent developments in the treatment of nsclc
-
2:54
considerations for duration and de-escalation of immunotherapy in lung cancer
-
1:23
optimizing treatment of alk nsclc: clinical realities
-
1:20:16
optimizing advanced nsclc biomarker testing, treatment and management session 1
-
41:11
optimizing treatment selection, sequencing, and tolerability in small cell lung cancer
-
5:50
optimizing maintenance therapy in non-small cell lung cancer
-
1:13
brain metastases and lung cancer: optimizing treatment using biomarkers
-
1:24:39
optimizing advanced nsclc biomarker testing, treatment and management session 3
-
10:01
optimizing immunotherapy in the nsclc treatment paradigm
-
1:32
the iaslc: implementing personalized medicine in lung cancer
-
37:26
accurate diagnosis and personalized treatment of nsclc for the interdisciplinary team
-
3:41
targeted therapy versus standards of care in metastatic nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
1:41
optimizing liquid biopsies for early detection in lung cancer
-
1:24:29
optimizing advanced nsclc biomarker testing, treatment and management session 2
-
3:28
the future of nsclc treatment
-
3:00
personalizing small-cell lung cancer treatment: subsets, chemoimmunotherapy, and future prospects